Newsletter
Camrelizumab for Advanced-Stage Esophageal Cancer, Urate-Elevating Inosine for Early Parkinson Disease, Low- vs High-Normal Oxygen Targets in the ICU, and more

JAMA Editor’s Summary

Camrelizumab for Advanced-Stage Esophageal Cancer, Urate-Elevating Inosine for Early Parkinson Disease, Low- vs High-Normal Oxygen Targets in the ICU, and more

Editor's Summary by Gregory Curfman, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the issue.
September 14, 2021

Camrelizumab for Advanced-Stage Esophageal Cancer, Urate-Elevating Inosine for Early Parkinson Disease, Low- vs High-Normal Oxygen Targets in the ICU, and more

Editor’s Summary by Gregory Curfman, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the September 14, 2021 issue.

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

Proudly supported by:

cover
How is Parkinson’s Disease Diagnosed? And How Is a Care Team Created? Parkinson’s disease can’t be diagnosed through a simple blood test or scan. After a referral from a primary care doctor, it often takes visits to a neurologist or movement disorder specialist before receiving a clinical diagnosis.